Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer Read more
IRX Therapeutics reports positive IRX-2 phase 2a head and neck squamous cell carcinoma clinical results Read more
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Read more
PharmaMar Starts a Quadruple Combination Study With Aplidin for the Treatment of Multiple Myeloma Read more